Related Experiment Video
Updated: Jun 22, 2025

08:40
Methyl-binding DNA capture Sequencing for Patient Tissues
Published on: October 31, 2016
8.6K
Identifying Differential Methylation in Cancer Epigenetics via a Bayesian Functional Regression Model
Farhad Shokoohi1, David A Stephens2, Celia M T Greenwood3,4,5
1Department of Mathematical Sciences, University of Nevada Las Vegas, Las Vegas, NV 89154, USA.
Biomolecules
|June 27, 2024
Summary
We developed DMCFB, a new Bayesian method for identifying differentially methylated cytosines (dmcs). DMCFB improves accuracy and consistency in detecting DNA methylation changes, crucial for understanding gene regulation and disease risk.
Area of Science:
- Genomics
- Epigenetics
- Bioinformatics
Background:
- DNA methylation is vital for gene regulation, disease susceptibility, and treatment outcomes.
- Next-generation sequencing provides single-nucleotide resolution of methylation patterns.
- Analyzing complex sequencing data to identify differential methylation presents significant computational challenges.
Purpose of the Study:
- To develop an efficient and accurate method for identifying differentially methylated cytosines (dmcs).
- To address the challenges posed by complex, high-dimensional sequencing data in methylation analysis.
Main Methods:
- Development of DMCFB, a novel method employing Bayesian functional regression for dmc identification.
- Performance evaluation using simulations to compare DMCFB against existing methods.
- Application of DMCFB to analyze DNA methylation data from acute promyelocytic leukemia patients and controls.
Main Results:
- DMCFB demonstrated superior performance compared to current methods in simulations, offering better data smoothing and imputation.
- Analysis of acute promyelocytic leukemia data revealed numerous novel dmcs.
- Enhanced consistency of differential methylation was observed within CpG islands and their shores.
- Differential methylation was detected at additional binding sites of the key fused gene implicated in the cancer.
Conclusions:
- DMCFB is an efficient and effective tool for identifying differentially methylated cytosines.
- The method enhances the discovery and consistency of differential methylation patterns.
- Findings provide new insights into the epigenetic landscape of acute promyelocytic leukemia, particularly concerning key gene targets.

